Macquarie Group LTD Nektar Therapeutics Transaction History

Macquarie Group LTD

  • $90.3 Billion
  • Q3 2024

A detailed history of Macquarie Group LTD transactions in Nektar Therapeutics stock. As of the latest transaction made, Macquarie Group LTD holds 256,385 shares of NKTR stock, worth $238,438. This represents 0.0% of its overall portfolio holdings.

Number of Shares
256,385
Previous 256,385 -0.0%
Holding current value
$238,438
Previous $317,000 5.05%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 21, 2023
SELL
$2.03 - $4.28 $5,188 - $10,939
-2,556 Reduced 0.99%
256,385 $579,000
Q3 2022

Nov 14, 2022
SELL
$3.04 - $5.14 $11,880 - $20,087
-3,908 Reduced 1.49%
258,941 $841,000
Q1 2022

May 16, 2022
SELL
$4.16 - $13.72 $8,711 - $28,729
-2,094 Reduced 0.79%
262,849 $1.42 Million
Q3 2021

Nov 12, 2021
SELL
$13.07 - $18.84 $34,779 - $50,133
-2,661 Reduced 0.99%
264,943 $4.76 Million
Q2 2021

Aug 13, 2021
BUY
$16.52 - $20.4 $60,380 - $74,562
3,655 Added 1.38%
267,604 $4.59 Million
Q1 2021

May 14, 2021
SELL
$16.56 - $25.46 $30,685 - $47,177
-1,853 Reduced 0.7%
263,949 $5.28 Million
Q3 2020

Nov 13, 2020
BUY
$16.59 - $24.79 $11,613 - $17,353
700 Added 0.26%
265,802 $4.41 Million
Q2 2020

Aug 11, 2020
BUY
$16.86 - $23.44 $18,832 - $26,182
1,117 Added 0.42%
265,102 $6.14 Million
Q1 2020

May 15, 2020
BUY
$14.47 - $27.96 $1.32 Million - $2.56 Million
91,385 Added 52.95%
263,985 $4.71 Million
Q4 2019

Feb 14, 2020
BUY
$15.87 - $23.12 $34,914 - $50,864
2,200 Added 1.29%
172,600 $3.73 Million
Q2 2019

Aug 14, 2019
BUY
$31.0 - $36.3 $133,300 - $156,090
4,300 Added 2.59%
170,400 $6.06 Million
Q4 2018

Feb 15, 2019
SELL
$30.43 - $56.65 $27,387 - $50,985
-900 Reduced 0.54%
166,100 $5.46 Million
Q3 2018

Nov 15, 2018
BUY
$46.46 - $68.49 $92,920 - $136,980
2,000 Added 1.21%
167,000 $10.2 Million
Q2 2018

Aug 14, 2018
BUY
$46.25 - $104.45 $6.92 Million - $15.6 Million
149,522 Added 966.03%
165,000 $8.06 Million
Q1 2018

May 11, 2018
SELL
$57.4 - $108.44 $1 Million - $1.89 Million
-17,468 Reduced 53.02%
15,478 $1.65 Million
Q4 2017

Feb 15, 2018
BUY
$23.02 - $60.5 $758,416 - $1.99 Million
32,946
32,946 $1.97 Million

Others Institutions Holding NKTR

# of Institutions
145
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $174M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email